Research and Markets: Retinoblastoma - Pipeline Review, H2 2013 Research Report

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/rj6q65/retinoblastoma) has announced the addition of the "Retinoblastoma - Pipeline Review, H2 2013" report to their offering.

'Retinoblastoma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Retinoblastoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Retinoblastoma.

Scope

- A snapshot of the global therapeutic scenario for Retinoblastoma.

- A review of the Retinoblastoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Retinoblastoma pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

Introduction

Retinoblastoma Overview

Therapeutics Development

Pipeline Products for Retinoblastoma - Overview

Clinical Stage Products

Early Stage Products

Retinoblastoma - Products under Development by Companies

Retinoblastoma - Products under Investigation by Universities/Institutes

Retinoblastoma - Companies Involved in Therapeutics Development

Retinoblastoma - Therapeutics Assessment

Drug Profiles

NTX-010 - Drug Profile

BL-8040 - Drug Profile

melphalan - Drug Profile

Nutlin-3 - Drug Profile

Drug for Retinoblastoma - Drug Profile

Retinoblastoma - Recent Pipeline Updates

Retinoblastoma - Product Development Milestones

Featured News & Press Releases

Appendix

List of Tables

List of Figures

Companies Mentioned

BioLineRx, Ltd.

Neotropix, Inc.

Icon Bioscience, Inc.

RXi Pharmaceuticals Corporation

For more information visit http://www.researchandmarkets.com/research/rj6q65/retinoblastoma

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology